Both Lck and Lyn overexpression/hyperactivation are considered relevant factors for CLL pathogenesis, and although Lck expression has been linked with resistance to chemotherapy, no association could be found with disease outcome (26). Here, LYN is linked to B-cell chronic lymphocytic leukemia.